Runpeng Li is a postdoctoral scholar at the USC Epstein Family Alzheimer’s Therapeutic Research Institute at the Keck School of Medicine of the University of Southern California. He earned his PhD from the Department of Mathematics at the University of California, Riverside, and completed a master’s degree at Northeastern University.
Li’s research centers on patterns of cognitive decline in preclinical Alzheimer’s disease and implications for clinical trial design. In 2026, he was the first author of the paper “Divergent patterns of cognitive decline in preclinical Alzheimer’s disease: Implications for secondary prevention trials,” published in Alzheimer’s & Dementia. The study identified three distinct trajectories of cognitive change using data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) study and highlighted the value of individualized approaches in secondary prevention trials.